Sanofi-aventis

Two CROs honored for employee training programs

Thursday, March 3, 2011 06:16 AM

Two global contract research organizations—Quintiles Transnational and Kendle—have been named to the Training Top 125 list, which recognizes excellence in employer-sponsored training and development programs.

More... »

FDA issues warning letter to Sanofi-aventis

Tuesday, March 1, 2011 08:00 AM

The FDA has warned Sanofi-Aventis’ U.S. unit for failing to submit reports of possible serious drug side effects in a timely manner. In a Jan. 28 letter made public last week, the FDA said an early response from the drugmaker and its "promised corrective actions are inadequate to address the deficiencies."

More... »

Sanofi’s $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

Tuesday, February 22, 2011 10:06 AM

Could last Wednesday’s $20 billion Sanofi-aventis acquisition of Genzyme signal the beginning of an industry trend in which big pharmaceutical companies stop buying each other and start buying robust biotechnology firms?

More... »

Covance and Sanofi-aventis ink landmark 10-year, $2.2 billion R&D outsourcing partnership

Monday, October 4, 2010 10:01 AM

Hailed as the largest outsourcing partnership between a contract research organization (CRO) and a pharmaceutical company, Covance and Sanofi-aventis have signed a 10-year agreement in which the CRO will provide France’s largest pharmaceutical company with a wide range of research and drug development services, and receive between $1.2 billion and $2.2 billion in revenue.

More... »

Phase Forward Appoints First Chief Privacy Officer

Thursday, December 24, 2009 07:40 AM

Phase Forward appointed long-time employee Michael Owings to the new role of chief privacy officer. Owings will oversee all privacy and data protection processes affecting Phase Forward’s customers and employees, and ensure compliance with all relevant regulations. He will also continue his duties as vice president, quality and regulatory compliance—a title he’s held since 2004.

More... »